SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs > Rosetta Genomics Ltd (ROSG)

RSI still at 66.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Penny Gold Mine Member Profile
 
Followed By 224
Posts 7,372
Boards Moderated 4
Alias Born 12/14/09
160x600 placeholder
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/23/2017 10:10:15 AM
Rosetta Genomics Closes Second Tranche of Previously Announced Private Placement of Convertible Debentures "Business Wire" - 2/23/2017 9:43:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 2/17/2017 6:01:42 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 2/16/2017 5:21:50 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/15/2017 8:42:17 AM
Securities Registration (foreign Private Issuer) (f-1/a) "Edgar (US Regulatory)" - 2/14/2017 4:39:39 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/14/2017 11:21:12 AM
Rosetta Genomics Reports Preliminary RosettaGX Reveal™ Financial Results for the 2016 Fourth Quarter and Year "Business Wire" - 2/8/2017 9:00:00 AM
Rosetta Genomics Announces Key U.S. Patent Allowances for Two RosettaGx RevealTM microRNAs "Business Wire" - 2/6/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/3/2017 5:27:19 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 1/26/2017 6:04:21 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/20/2016 4:28:02 PM
Securities Registration (foreign Private Issuer) (f-1) "Edgar (US Regulatory)" - 12/8/2016 4:10:35 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/8/2016 4:09:20 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 11/28/2016 4:49:50 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/25/2016 4:29:20 PM
Rosetta Genomics Announces Pricing of $5 Million Concurrent Registered Direct and Private Placement Offering "Business Wire" - 11/23/2016 3:35:00 PM
Rosetta Genomics Enters Research Collaboration using microRNA Biomarkers to Predict Response to Leading Immuno-Oncology Drug ... "Business Wire" - 11/21/2016 8:00:00 AM
Clinical Validation Study for RosettaGX Reveal Published in the Journal of Clinical Pathology "Business Wire" - 10/27/2016 8:15:00 AM
RosettaGX Reveal™ Analytical Validation Study Featured on the Cover of the October Issue of Cancer Cytopathology "Business Wire" - 10/24/2016 8:30:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/20/2016 5:04:26 PM
Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer "Business Wire" - 10/20/2016 8:40:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/14/2016 4:53:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/13/2016 4:57:03 PM
Rosetta Genomics Fortifies Intellectual Property Portfolio with Two New Patent Allowances for its Novel microRNA Platform Tec... "Business Wire" - 10/3/2016 8:00:00 AM
Penny Gold Mine   Thursday, 05/31/12 08:32:15 AM
Re: None
Post # of 1875 
RSI still at 66.

needs to cool off still for next run.IMO

11 may be enough


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist